Get the Stockscreener App
110.32
1.08%
-1.20
Pre-market:
110.60
0.28
+0.25%
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $110.32, with a volume of 1.43M.
It is down -1.08% in the last 24 hours and down -2.27% over the past month.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
See More
Previous Close:
$111.52
Open:
$110.71
24h Volume:
1.43M
Relative Volume:
1.63
Market Cap:
$13.25B
Revenue:
$2.72B
Net Income/Loss:
$254.30M
P/E Ratio:
53.38
EPS:
2.0665
Net Cash Flow:
$564.37M
1W Performance:
-2.55%
1M Performance:
-2.27%
6M Performance:
-9.60%
1Y Performance:
+2.15%
1-Day Range:
$109.96
$112.44
1-Week Range:
$109.96
$120.39
52-Week Range:
$97.31
$129.50
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
110.32 | 13.25B | 2.72B | 254.30M | 564.37M | 2.0665 |
|
TMO
Thermo Fisher Scientific Inc
|
508.90 | 191.99B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
204.09 | 145.87B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
117.33 | 33.47B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IDXX
Idexx Laboratories Inc
|
406.29 | 33.04B | 3.90B | 887.87M | 798.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
181.43 | 31.99B | 15.41B | 1.37B | 2.11B | 7.50 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-08-24 | Initiated | Leerink Partners | Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
Learn to Evaluate (RVTY) using the Charts - Stock Traders Daily
Revvity at Leerink Global Healthcare Conference: Strategic Resilience Amid Challenges - Investing.com
Jones Financial Companies Lllp Acquires 1,228 Shares of Revvity, Inc. (NYSE:RVTY) - Defense World
Mutual of America Capital Management LLC Cuts Stock Position in Revvity, Inc. (NYSE:RVTY) - Defense World
PerkinElmer Stock Price | RVTY Stock Quote, News, and History - Markets Insider
Sanctuary Advisors LLC Purchases Shares of 1,872 Revvity, Inc. (NYSE:RVTY) - Defense World
Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay - Technology Networks
Revvity, Inc. (NYSE:RVTY) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Revvity Expands Measles Testing Accessibility with EUROIMMUN Anti-Measles Virus ELISA 2.0 - Lab Manager Magazine
Revvity's (NYSE:RVTY) Solid Earnings Have Been Accounted For Conservatively - Yahoo Finance
What Does the Market Think About Revvity? - Benzinga
Private Advisor Group LLC Grows Stock Holdings in Revvity, Inc. (NYSE:RVTY) - Defense World
Revvity Says Euroimmun Gets CE Mark for Measles Antibody Detection -March 03, 2025 at 10:28 am EST - Marketscreener.com
High-Throughput Screening Technology Analysis and Global - GlobeNewswire
High-Throughput Screening Technology Analysis and Global Markets 2021-2024 & 2025-2029 with Danaher, Thermo Fisher Scientific., Charles River Laboratories, Revvity and Bio-Rad Laboratories Leading - Yahoo Finance
Groundbreaking Measles Test From Revvity Could Transform Diagnostics in Underserved Regions - StockTitan
Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Jefferies raises Revvity stock price target to $130, maintains Hold - MSN
Is Revvity, Inc.'s (NYSE:RVTY) Stock Price Struggling As A Result Of Its Mixed Financials? - Simply Wall St
Principal Financial Group Inc. Sells 4,253 Shares of Revvity, Inc. (NYSE:RVTY) - Defense World
New York State Common Retirement Fund Reduces Stock Position in Revvity, Inc. (NYSE:RVTY) - Defense World
Do Options Traders Know Something About Revvity (RVTY) Stock We Don't? - MSN
Revvity Predicts Lower 2025 Earnings Despite Strong Fourth Quarter - Finimize
Revvity: Acquisitions In High-Growth Sectors, Excellent Debt Levels Create Notable Growth Potential - Seeking Alpha
Revvity, Inc. (NYSE:RVTY) Shares Acquired by Vontobel Holding Ltd. - Defense World
Are Wall Street Analysts Bullish on Revvity Stock? - MSN
Revvity ignites scientific breakthroughs at SLAS2025 - MSN
Are Wall Street Analysts Bullish On Revvity Stock? - Barchart
Revvity, Inc. (NYSE:RVTY) Shares Acquired by Empowered Funds LLC - Defense World
Massachusetts Court Grants Permanent Injunction To Revvity Against Cloud Software Over Spotfire - Nasdaq
Revvity Wins Permanent Injunction Enforcing Agreements With Cloud Software Group - Marketscreener.com
Revvity Wins Permanent Injunction Against Cloud Software Group -February 20, 2025 at 01:06 pm EST - Marketscreener.com
Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group - Business Wire
Revvity to Present at Upcoming Investor Conferences - Business Wire
How To Trade (RVTY) - Stock Traders Daily
Louisiana State Employees Retirement System Sells 400 Shares of Revvity, Inc. (NYSE:RVTY) - Defense World
Bretton Fund: “Revvity (RVTY) Has Been On A Roller Coaster Ride The Last Few Years” - Insider Monkey
Revvity files complaint against Cloud Software Group - MSN
Sumitomo Mitsui Trust Group Inc. Purchases 6,814 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
abrdn plc Decreases Position in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Mirae Asset Global Investments Co. Ltd. Grows Stake in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Mirae Asset Global Investments Co. Ltd. Buys 3,542 Shares of Revvity, Inc. (NYSE:RVTY) - Defense World
Revvity, Inc. (NYSE:RVTY) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Does Revvity (NYSE:RVTY) Have A Healthy Balance Sheet? - Simply Wall St
Janney Montgomery Scott LLC Purchases 3,672 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Slocum Gordon & Co LLP Sells 556,579 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Trust Point Inc. Takes $513,000 Position in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity (NYSE:RVTY) Is Posting Promising Earnings But The Good News Doesn’t Stop There - Yahoo Finance
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):